Abera Bioscience AB (XSAT:ABERA) Total Current Assets : kr9.83 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Abera Bioscience AB Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Abera Bioscience AB's total current assets for the quarter that ended in Mar. 2024 was kr9.83 Mil.

Abera Bioscience AB Total Current Assets Historical Data

The historical data trend for Abera Bioscience AB's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abera Bioscience AB Total Current Assets Chart

Abera Bioscience AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

3.00

1.08

12.44

17.69

7.44

Abera Bioscience AB Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial														14.60	7.80	2.85	7.44	9.83

Abera Bioscience AB Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Abera Bioscience AB's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	3.296	+	4.141	+	0	+	0.0010000000000003
	=	7.44

Abera Bioscience AB's Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	6.654	+	3.178	+	0	+	-0.0010000000000012
	=	9.83

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Abera Bioscience AB (XSAT:ABERA) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Abera Bioscience AB's Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	6.654	-	2.452	+	0.75 * 0	+	0.5 * 0
=	4.20

Abera Bioscience AB Total Current Assets Related Terms

Thank you for viewing the detailed overview of Abera Bioscience AB's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Abera Bioscience AB (XSAT:ABERA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abera Bioscience AB (XSAT:ABERA) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Svetsarvagen 15, Solna, SWE, SE-17141

Website

https://www.aberabio.com

Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.

Abera Bioscience AB (XSAT:ABERA) Headlines

No Headlines